MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 21, 2005
W.D. Crotty
CNS Strips for Profits Nasal strip sales soar, and so do the company's third-quarter profits. mark for My Articles similar articles
The Motley Fool
February 9, 2004
Paul Elliott
Small Cap Floating on Air CNS, maker of Breathe Right nasal strips, is a stock I love. The attraction is financial. And CNS's financials are a thing of beauty, starting with a pile of cash -- $46.87 million -- and not a penny of debt. mark for My Articles similar articles
The Motley Fool
April 29, 2005
W.D. Crotty
CNS Has a Nose for Cash The company that gave us Breathe Rights continues to build a large cash hoard. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 22, 2004
W.D. Crotty
CNS's Whiff of Fresh Air The company's Breathe Right franchise is a real money machine. Net income of $0.24 a share beat analyst estimates by $0.05 and the top end of the company's guidance. mark for My Articles similar articles
The Motley Fool
November 29, 2004
Rich Duprey
A Patented Challenge to CNS The Patent and Trademark Office is reconsidering two patents of the nasal strips maker. Investors took notice and slapped the company down 8%, which ought to present an opportunity to pick up shares. mark for My Articles similar articles
The Motley Fool
August 4, 2005
Nathan Parmelee
Still a Green Monster Spectacular earnings growth and a strong margin make for a very strong quarter at consumer products company CNS. mark for My Articles similar articles
The Motley Fool
November 17, 2005
Nathan Parmelee
Dueling Fools: CNS Bull A large part of the reason this consumer products company's shares have advanced 121% over the last two years is because the company's shares didn't reflect the strong profitability of the business or its growth prospects. mark for My Articles similar articles
The Motley Fool
January 26, 2006
Nathan Parmelee
CNS Is All Stuffed Up The company that gave us Breathe Right nasal strips missed analyst estimates and the stock gets crushed. mark for My Articles similar articles
The Motley Fool
June 24, 2004
Nathan Parmelee
CNS Is a Green Monster CNS packs an impressive amount of cash and, even more impressively, keeps piling up the green stuff. mark for My Articles similar articles
The Motley Fool
January 24, 2006
Rich Smith
Foolish Forecast: Simply CNS Analysts believe that CNS will grow at an annualized rate of 18% in the long term. That's tremendous, but perhaps not enough to justify its P/E ratio of 21, or its price-to-free cash flow ratio of 21. mark for My Articles similar articles
The Motley Fool
October 10, 2006
Bill Mann
Want to Find Buyout Candidates? Mergers don't always take place on great terms for shareholders, nonetheless, many investors continue to seek out these kinds of situations. It's part of the power of small-cap companies -- often they're the minnows that the big fish seek to make themselves grow. mark for My Articles similar articles
The Motley Fool
November 17, 2005
W.D. Crotty
Dueling Fools: CNS Bear Although the consumer products maker's stock has risen 125% since 2003, it is just now reaching levels last seen in 1996. Just when investors thought they had a jackrabbit, they're reminded that this company doesn't traditionally move a mile a minute. mark for My Articles similar articles
The Motley Fool
October 29, 2004
Rich Smith
3 Gems for the Taking Mr. Market has already forgotten again that these companies exist, but we haven't. Here are three classic recommendations that no one on Wall Street is watching. Still high quality. Still low price. mark for My Articles similar articles
The Motley Fool
May 8, 2006
Rick Aristotle Munarriz
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Let's take a closer look at four of the companies that inched their payouts higher this past week. PepsiCo... CNS... etc. mark for My Articles similar articles
The Motley Fool
November 17, 2005
W.D. Crotty
Dueling Fools: CNS Bear Rebuttal Do what insiders are doing. Over the last six months, in 19 separate transactions, the consumer products company sold 237,439 shares. There were no purchases. mark for My Articles similar articles
The Motley Fool
October 9, 2006
Nathan Parmelee
CNS Shareholders Can Breathe Easy CNS will be acquired by GlaxoSmithKline. There should be no bitterness on either side in this deal. CNS shareholders are getting amply rewarded. mark for My Articles similar articles
The Motley Fool
December 29, 2004
Rich Smith
Panning for Gold In an equity universe with thousands of stocks to choose from, how do you sort the "good stuff" from the rubbish? Here are seven easy steps to show you how to tell a possible gem from a probable rock. mark for My Articles similar articles
The Motley Fool
November 3, 2006
Smell the Roses at CNS: Fool by Numbers The consumer health-care products maker released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 9, 2005
Rich Smith
Hunting Baby Elephants Wouldn't you like to find -- and buy -- tomorrow's 6-ton business behemoths while they're still small? Here's how to do it. mark for My Articles similar articles
The Motley Fool
July 20, 2004
Rick Aristotle Munarriz
Margins of Error Profit margins matter. It's why we can get more excited about a company with rich margins when it grows sales -- we know that much more of the incremental dollar will work its way down to the bottom line unscathed. mark for My Articles similar articles